Building on these advances, a novel ADC format for triple-negative BC utilizes single-chain variable fragments (scFvs) targeting EGFR or the epithelial cell adhesion molecule (EpCAM) instead of full-length antibodies. This evidence concerns the gene EGFR and breast cancer.